Computational studies demonstrating dithymoquinone of Nigella sativa as a potential anti-dengue agent: Short review

Abstract

Dengue is acute tropical infectious illness, which is spread by mosquitoes, has presented a significant threat to public health worldwide. Unfortunately, there are no drugs that have been clinically proven to be effective at treating or preventing dengue. The development of some drugs is significantly hampered by our incomplete understanding of dengue pathogenesis. This short review provides a brief description of potential action against DENV of dithymoquinone to develop an anti-DENV inhibitor. In-vitro, in-vivo and clinical trials are required to establish the effectiveness and safety of dithymoquinone as an anti-dengue therapy, even though computational studies have demonstrated antiviral activity against DENV.

Keywords

Dengue / DENV / Anti-DENV / Nigella sativa / Dithymoquinone

References

[1] García-ArizaLL, González-Rivillas N, Díaz-AguirreCJ, Rocha-RoaC, Padilla-Sanabria L, Castaño-OsorioJC. Antiviral activity of an indole-type compound derived from natural products, identified by virtual screening by interaction on dengue virus NS5 protein. Viruses. 2023;15(7):1563.

[2] GoldingMA, KhouriNK, AndersonKB, Wood TD, SandifordSL. The use of natural products in Latin America and the Caribbean for blocking dengue infection in mosquito cells. Frontiers in Virology. 2023;3:1130171.

[3] TorresJR, OrdunaTA, Piña-PozasM, Vázquez-VegaD, Sarti E. Epidemiological characteristics of dengue disease in Latin America and in the Caribbean: a systematic review of the literature. J Trop Med. 2017;2017.

[4] RoneyM, DubeyA, NasirMH, et al. Computational evaluation of quinones of Nigella sativa L. as potential inhibitor of dengue virus NS5 methyltransferase. J Biomol Struct Dyn. 2023:1–11.

[5] LeeMF, WuYS, PohCL. Molecular mechanisms of antiviral agents against dengue virus. Viruses. 2023;15(3):705.

[6] SouzaLR, Colonna JG, ComodaroJM, NavecaFG. Using amino acids co-occurrence matrices and explainability model to investigate patterns in dengue virus proteins. BMC Bioinf. 2022;23(1):1–19.

[7] AhmadMF, AhmadFA, AshrafSA, et al. An updated knowledge of Black seed (Nigella sativa Linn.): review of phytochemical constituents and pharmacological properties. J Herb Med. 2021;25:100404.

[8] ShafiqH, AhmadA, MasudT, Kaleem M. Cardio-protective and anti-cancer therapeutic potential of Nigella sativa. Iranian journal of basic medical sciences. 2014;17(12):967.

[9] AhmadA, HusainA, MujeebM, et al. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac J Trop Biomed. 2013;3(5):337–352.

[10] ElsharkawyER, Abdallah EM, MarkbAA. Potential cytotoxic, antifungal, and antioxidant activity of dithymoquinone and thymoquinone. Journal of Hunan University Natural Sciences. 2021;48(9).

[11] EsharkawyER, Almalki F, HaddaTB. In vitro potential antiviral SARS-CoV-19-activity of natural product thymohydroquinone and dithymoquinone from Nigella sativa. Bioorg Chem. 2022;120:105587.

[12] MukhtarM, KhanHA. Exploring the inhibitory potential of Nigella sativa against dengue virus NS2B/NS3 protease and NS5 polymerase using computational approaches. RSC Adv. 2023;13(27):18306–18322.

[13] RajapandianR, Kadarkarai M. Encapsulation of silver nano crystals using Salvinia molesta against the Anopheles stephensi and oxidative stress enzyme activity of larvivorous fish. Journal of Natural Pesticide Research. 2023;3:100022.

[14] KovendanK, Fabiola M, JebanesanA, RajaganeshR. Green synthesis of Malvastrum coromandelianum fabricated AgNPs: anti-dengue and mosquitocidal studies. Inorg Chem Commun. 2024:112067.

[15] PratheebaT, Taranath V, GopalDS, NatarajanD. Antidengue potential of leaf extracts of Pavetta tomentosa and Tarenna asiatica (Rubiaceae) against dengue virus and its vector Aedes aegypti (Diptera: Culicidae). Heliyon. 2019;5(11):e02732.

[16] RahmanMM, BiswasS, IslamKJ, et al. Antiviral phytochemicals as potent inhibitors against NS3 protease of dengue virus. Comput Biol Med. 2021;134:104492.

[17] MaideenNMP, HaddaTB, AlmalkiFA, Laarousi H, SolimanSS, KawsarSM. Black Seeds (Nigella Sativa) for the Management of Dengue Viral Disease: POM Analyses for the Identification of New Antiviral Pharmacophore Sites. 2023.

[18] OkanoY, Saito-Tarashima N, KurosawaM, et al. Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents. Bioorg Med Chem. 2019;27(11):2181–2186.

[19] SankarasubramanianJ, Pavithra KB, KavithaB. Identification of potent inhibitor for RNA dependent RNA polymerase (RDRP) of dengue virus serotype-3: a molecular docking study. J Appl Bioinform Comput Biol. 2015;4(1):2.

[20] ZandiK, TeohBT, SamSS, Wong PF, MustafaMR, AbuBakarS. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J. 2011;8(1):1–11.

[21] AnusuyaS, Gromiha MM. Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation. J Biomol Struct Dyn. 2017;35(13):2895–2909.

[22] ShorobiFM, NisaFY, SahaS, et al. Quercetin: a functional food-flavonoid incredibly attenuates emerging and Re-emerging viral infections through immunomodulatory actions. Molecules. 2023;28(3):938.

[23] PurohitP, SahooS, PandaM, Sahoo PS, MeherBR. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies. J. Mol. Model. 2022;28(11):365.

RIGHTS & PERMISSIONS

2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.